Executive Director @ TransPharMac (April 2022 - Present)
Chief Scientific Officer @ (March 2021 - September 2023)
Chief Operating Officer @ (May 2019 - March 2021)
Vice President Translational Medicine and Executive Board Member @ (September 2014 - April 2019)
VP Clinical Development @ (January 2016 - July 2016)
Senior Director Translational Medicine @ (October 2010 - August 2014)
Vice President Exploratory and Translational Development @ (January 2009 - October 2010)
Senior Director, Exploratory and Translational Development @ (January 2007 - January 2009)
Senior Director, Drug Metabolism and Pharmacokinetics @ (January 2005 - January 2007)
Manager, DMPK @ (November 2001 - January 2005)
Scientific Manager and Study Director @ Inveresk Research (March 1994 - October 2001)
Postdoctoral Research Associate @ University of Newcastle upon Tyne (August 1991 - March 1994)
Nigel McCracken Education
King's College London
Master's degree (Clinical Pharmacology)
2014-2015
Newcastle University
PhD (Biochemical Toxicology)
1988-1991
University of Strathclyde
BSc (Biochemistry, Pharmacology)
1984-1988
Earnock High School 1978-1984
Nigel McCracken Skills
ADME
Bioanalysis
Biomarker Development
Biomarker Manufacturing
Biomarkers
Biotechnology
Cancer Research
Clinical Development
Clinical Pharmacology
Clinical Research
Clinical Trials
Corporate Financial Reporting
DMPK
Development Projects
Drug Development
Drug Discovery
Drug Metabolism
Executive Development
Expense Reports
Expenses
Immunology
Leadership
Leading Development Teams
Modeling and Simulation
Oncology
Personalized Medicine
Pharmaceutical Industry
Pharmacodynamics
Pharmacokinetics
Pharmacology
Pharmacometrics
Post acute infection syndromes (long COVID and ME/CFS)
Regulatory Affairs
Regulatory Submissions
Respiratory Therapy
Scientific Background
Therapeutic Areas
Toxicology
Translational Medicine
Nigel McCracken Summary
Nigel McCracken, based in Edinburgh, GB, is currently a Chief Operating Officer at Virax Biolabs. Nigel McCracken brings experience from previous roles at TransPharMac , BerGenBio ASA, NuCana plc and Debiopharm International SA. Nigel McCracken holds a 2014 - 2015 Master's degree in Clinical Pharmacology @ King's College London. With a robust skill set that includes ADME, Bioanalysis, Biomarker Development, Biomarker Manufacturing, Biomarkers and more. Nigel McCracken has 1 emails on RocketReach.
Looking for a different Nigel McCracken?
Find contact details for 700 million professionals.